Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1999-7-28
pubmed:abstractText
Oxazolidinones are antibacterial agents that act primarily against gram-positive bacteria by inhibiting protein synthesis. The binding of oxazolidinones to 70S ribosomes from Escherichia coli was studied by both UV-induced cross-linking using an azido derivative of oxazolidinone and chemical footprinting using dimethyl sulphate. Oxazolidinone binding sites were found on both 30S and 50S subunits, rRNA being the only target. On 16S rRNA, an oxazolidinone footprint was found at A864 in the central domain. 23S rRNA residues involved in oxazolidinone binding were U2113, A2114, U2118, A2119, and C2153, all in domain V. This region is close to the binding site of protein L1 and of the 3' end of tRNA in the E site. The mechanism of action of oxazolidinones in vitro was examined in a purified translation system from E. coli using natural mRNA. The rate of elongation reaction of translation was decreased, most probably because of an inhibition of tRNA translocation, and the length of nascent peptide chains was strongly reduced. Both binding sites and mode of action of oxazolidinones are unique among the antibiotics known to act on the ribosome.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-1383931, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2425339, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2449210, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2461163, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2468070, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2470511, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2583120, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2690012, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-2853815, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-3045816, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-3058018, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-3060846, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-3122849, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-3241548, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-3323531, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-3435127, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-6178442, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-7585249, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-7892205, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-7918447, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-7937081, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-8080098, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-8576909, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-8633041, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-8726028, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-9122161, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-9281424, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-9281425, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-9333036, http://linkedlifedata.com/resource/pubmed/commentcorrection/10411137-9333037
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1355-8382
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
939-46
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors.
pubmed:affiliation
Institute of Molecular Biology, University of Witten/Herdecke, Witten, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't